Yoon DH - Search Results

1

Single-Agent Mosunetuzumab Shows Durable Complete Responses in Patients With Relapsed or Refractory B-Cell Lymphomas: Phase I Dose-Escalation Study.

Budde LE, Assouline S, Sehn LH, Schuster SJ, Yoon SS, Yoon DH, Matasar MJ, Bosch F, Kim WS, Nastoupil LJ, Flinn IW, Shadman M, Diefenbach C, O'Hear C, Huang H, Kwan A, Li CC, Piccione EC, Wei MC, Yin S, Bartlett NL. Budde LE, et al. Among authors: yoon ss, yoon dh. J Clin Oncol. 2022 Feb 10;40(5):481-491. doi: 10.1200/JCO.21.00931. Epub 2021 Dec 16. J Clin Oncol. 2022. PMID: 34914545 Free PMC article. Clinical Trial.

2

Phase II study of erlotinib as a salvage treatment for non-small-cell lung cancer patients after failure of gefitinib treatment.

Lee DH, Kim SW, Suh C, Yoon DH, Yi EJ, Lee JS. Lee DH, et al. Among authors: yoon dh. Ann Oncol. 2008 Dec;19(12):2039-42. doi: 10.1093/annonc/mdn423. Epub 2008 Jul 21. Ann Oncol. 2008. PMID: 18644828 Free PMC article. Clinical Trial.

3

A phase I study of S-1 treatment with a 3 week schedule in advanced biliary cancer patients with or without hepatic dysfunction.

Yoon DH, Lee HJ, Hong YS, Kim KP, Lee SS, Lee JL, Chang HM, Ryu MH, Kang YK, Lee JS, Kim TW. Yoon DH, et al. Invest New Drugs. 2011 Apr;29(2):332-9. doi: 10.1007/s10637-009-9378-6. Epub 2009 Dec 30. Invest New Drugs. 2011. PMID: 20041339 Clinical Trial.

4

Pyridoxine is not effective to prevent hand-foot syndrome associated with capecitabine therapy: results of a randomized, double-blind, placebo-controlled study.

Kang YK, Lee SS, Yoon DH, Lee SY, Chun YJ, Kim MS, Ryu MH, Chang HM, Lee JL, Kim TW. Kang YK, et al. Among authors: yoon dh. J Clin Oncol. 2010 Aug 20;28(24):3824-9. doi: 10.1200/JCO.2010.29.1807. Epub 2010 Jul 12. J Clin Oncol. 2010. PMID: 20625131 Clinical Trial.

5

FDG-PET as a potential tool for selecting patients with advanced non-small cell lung cancer who may be spared maintenance therapy after first-line chemotherapy.

Yoon DH, Baek S, Choi CM, Lee DH, Suh C, Ryu JS, Moon DH, Lee JS, Kim SW. Yoon DH, et al. Clin Cancer Res. 2011 Aug 1;17(15):5093-100. doi: 10.1158/1078-0432.CCR-10-2791. Epub 2011 Jun 14. Clin Cancer Res. 2011. PMID: 21673067 Clinical Trial.

6

A phase I/II study of bortezomib plus CHOP every 2 weeks (CHOP-14) in patients with advanced-stage diffuse large B-cell lymphomas.

Kim JE, Yoon DH, Jang G, Lee DH, Kim S, Park CS, Huh J, Kim WS, Park J, Lee JH, Lee SI, Suh C. Kim JE, et al. Among authors: yoon dh. Korean J Hematol. 2012 Mar;47(1):53-9. doi: 10.5045/kjh.2012.47.1.53. Epub 2012 Mar 28. Korean J Hematol. 2012. PMID: 22479278 Free PMC article.

7

Extranodal natural killer/T-cell lymphoma from skin or soft tissue: suggestion of treatment from multinational retrospective analysis.

Ahn HK, Suh C, Chuang SS, Suzumiya J, Ko YH, Kim SJ, Huh JR, Yoon DH, Oh SY, Kim JS, Lee SI, Park KW, Hsieh PP, Nakamura S, Yoshino T, Ito K, Nagatani T, Oshimi K, Suzuki R, Kim WS. Ahn HK, et al. Among authors: yoon dh. Ann Oncol. 2012 Oct;23(10):2703-2707. doi: 10.1093/annonc/mds096. Epub 2012 Apr 29. Ann Oncol. 2012. PMID: 22547542 Free article.

8

Bortezomib in combination with CHOP as first-line treatment for patients with stage III/IV peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 trial.

Kim SJ, Yoon DH, Kang HJ, Kim JS, Park SK, Kim HJ, Lee J, Ryoo BY, Ko YH, Huh J, Yang WI, Kim HK, Min SK, Lee SS, Do IG, Suh C, Kim WS; Consortium for Improving Survival of Lymphoma (CISL) investigators. Kim SJ, et al. Among authors: yoon dh. Eur J Cancer. 2012 Nov;48(17):3223-31. doi: 10.1016/j.ejca.2012.06.003. Epub 2012 Jul 4. Eur J Cancer. 2012. PMID: 22770877 Clinical Trial.

9

High-dose chemotherapy and autologous stem-cell transplantation in Korean patients with relapsed or refractory Hodgkin lymphoma.

Park K, Yoon DH, Kim S, Park CS, Huh J, Lee SW, Suh C. Park K, et al. Among authors: yoon dh. Int J Hematol. 2013 Feb;97(2):256-62. doi: 10.1007/s12185-013-1267-2. Epub 2013 Jan 26. Int J Hematol. 2013. PMID: 23355263

10

Plerixafor use for peripheral blood stem cell mobilization in Korea.

Kim SJ, Yoon DH, Yang DH, Eom HS, Cho SG, Yoon SS, Lee JH, Kim WS, Suh C. Kim SJ, et al. Among authors: yoon ss, yoon dh. Blood Res. 2013 Jun;48(2):72-3. doi: 10.5045/br.2013.48.2.72. Blood Res. 2013. PMID: 23826573 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

660 results

Search Page